Hakkımızda
1983 yılında kurulan Vefa İlaç; ilaç, gıda takviyesi ve kozmetik ürünlerin araştırılması, geliştirilmesi ve üretilmesi alanında faaliyet göstermektedir.
Köklü Geçmiş, İleriye Bakan Kurum
Vefa İlaç, yarım asra yaklaşan tecrübesi ile ulusal ve uluslararası ölçekte üretim yapmaktadır. Beylikdüzü/İstanbul’daki modern üretim tesisimiz ile Kırklareli’ndeki fabrikamız; tablet, film kaplı tablet, kapsül, şurup, damla, krem ve jel formlarını tek çatı altında barındırır.
Ar-Ge merkezimiz, yüksek kaliteli formülasyonların geliştirilmesinde öncü rol oynar. Patent ve marka tescil sayımızla Türkiye ilaç endüstrisinde en aktif Ar-Ge merkezlerinden biriyiz.
Our Mission, Vision & Strategy
Our Mission
To make a sustainable contribution to human health by developing accessible, reliable, innovative and high-quality solutions in the fields of pharmaceuticals and food supplements — through our scientific expertise, strong R&D infrastructure and advanced manufacturing technologies.
Our Vision
To become a reliable, innovative and internationally recognized Turkish health brand that — with its expertise in science, R&D and advanced manufacturing technologies — delivers the health solutions it develops to world markets through a strong export network.
Our Strategy
To create sustainable value in existing and new markets through export-oriented growth, by manufacturing the high value-added health products we develop with our R&D strength to international quality standards.
AR-GE ve Üretim Gücümüzü Keşfedin
Modern tesislerimiz, geniş ürün portföyümüz ve Ar-Ge altyapımız hakkında daha fazla bilgi edinin.
Our History
The Vefa İlaç Journey
Key milestones from our founding to today.
- 2012
Founded
Vefa İlaç was officially established.
- 2013
TR GMP Approval
Received TR GMP approval and started manufacturing operations.
- 2014
ISO 9001 & ISO 13485
Obtained ISO 9001 and ISO 13485 quality management certifications.
- 2016
First Generic Drug License
Received the first generic drug manufacturing license in Türkiye.
- 2018
Export GMP Certificates
Obtained export GMP certificates from countries such as Azerbaijan and Iraq.
- 2018
VEFAR-GE R&D Center
The VEFAR-GE Research & Development Center was established.
- 2018
Generic Drug Licenses Reached 29
Our number of generic drug licenses reached 29.
- 2020
Expanding Production Portfolio
Our production portfolio surpassed 115 products, with more than 6 million boxes produced.
- 2024
Growing Exports and Portfolio
40 licensed products and over 135 food-supplement SKUs were exported to 36 different countries.
- 2026
Pilot Production
Within our future vision, we aim to bring a pilot production line online.
- 2028
EU GMP Certification
European Union GMP certification, targeted as part of our future vision.